Aptus Pharma Ltd
BSE: 544529
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q2 FY27 | Q2 FY25 |
|---|---|---|---|
| INCOME | |||
| Revenue | 14.38-70.6% | 48.92+240.2% | 14.38 |
| Other Income | 0.01-66.7% | 0.04+260.0% | 0.01 |
| Total Income | 14.39-70.6% | 48.96+240.2% | 14.39 |
| EXPENSES | |||
| Expenditure | 12.04-71.4% | 42.13+249.9% | 12.04 |
| Tax | 0.60-65.5% | 1.75+191.7% | 0.60 |
| PROFIT | |||
| PBT | 2.35-65.6% | 6.83+190.5% | 2.35 |
| Net Profit | 1.75-65.6% | 5.08+190.1% | 1.75 |
| KEY METRICS | |||
| OPM % | 12.00% | — | 16.34% |
| NPM % | 12.14%+1.77pp | 10.37%-1.80pp | 12.17% |
| EPS | 3.46+16.9% | 2.96 | — |
Corporate Events
Board MeetingAPPL
202612Nov
Board Meeting
The meeting of the Board of Directors is scheduled to be hel…
BSE Filing ↗ Board MeetingAPPL
202620Oct
Board Meeting
The Board of Directors considered and approved the Unaudited…
BSE Filing ↗ Board MeetingAPPL
202614Sep
Board Meeting
The Annual General Meeting will be held to transact the foll…
BSE Filing ↗ Board MeetingAPPL
20268Aug
Board Meeting
To consider, evaluate and deliberate upon the proposal for r…
BSE Filing ↗ Board MeetingAPPL
202624Mar
Board Meeting
To consider and recommend an increase in Authorized Share Ca…
BSE Filing ↗